Scientists have discovered a new way to predict which cancer tumours will become aggressive before they spread – paving the way for treatments to stop the disease in its tracks.A new study, published ...

I recently heard about a type of skin cancer called Merkel cell carcinoma. I’m not familiar with this condition. Can you explain what it is? Do I need to do anything different to protect myself?

During a Case-Based Roundtable® event, Evan J. Lipson, MD, moderated a discussion on the tolerability of immunotherapy in metastatic melanoma and when to stop therapy.

Million Private Placement Financing from Existing Investors$2.0 Million Funding Advance from the Cancer Prevention and Research Institute of ...

A combination immunotherapy may help cure a majority of patients with melanoma -- a deadly skin cancer -- that has spread to ...

My 36-year-old sister recently noticed an unusual mole on her shoulder. She is scheduled for some tests. Her primary care ...

Page Six can confirm that the woman, El Salvador immigrant Julia Umana, filed her lawsuit on Thursday — the day after Mellencamp underwent brain surgery.

Bristol Myers Squibb's Opdualag (relatlimab/Opdivo) fails Phase 3 melanoma trial, adding to mixed results for LAG-3/PD-1 ...

The failure in adjuvant melanoma could cause BMS and Opdualag to miss out on a market opportunity that is nearly twice as ...

Upon Opdualag’s approval in 2022 as a first-in-class cancer immunotherapy, Bristol Myers Squibb was anxious to explore its potential in a variety of indications. | Bristol Myers Squibb is striking out ...

Replimune's innovative cancer therapies, strong cash reserves, and FDA support position it to disrupt oncology markets. Click ...